2nd Quarter - Report

BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY

Firm
Client
Income
—
Expenses
$270,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax

LobbyistCovered position, as disclosed
JESSICA JOHNSTON —
ADAM LOTSPIKE —
TODD SPANGLER —
ELIZABETH WOODY —

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 692 (116th), H.R. 2207 (116th)

Veterans VET

Issues related to Veterans Affairs procurement of medical devices

LobbyistCovered position, as disclosed
ADAM LOTSPIKE —
TODD SPANGLER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

China tariffs Steel aluminum tariffs

LobbyistCovered position, as disclosed
ADAM LOTSPIKE —
TODD SPANGLER —
ELIZABETH WOODY —

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Civil Rights/Civil Liberties CIV

H.R.5, Equality Act of 2019

LobbyistCovered position, as disclosed
ADAM LOTSPIKE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5 (116th)

Medicare/Medicaid MMM

H.R.3584, Laboratory Access for Beneficiaries Act

LobbyistCovered position, as disclosed
ADAM LOTSPIKE —

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3584 (116th)

Budget/Appropriations BUD

NIH funding Global health funding CDC funding

LobbyistCovered position, as disclosed
DANNY LY —

Contacted: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

S.1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act

LobbyistCovered position, as disclosed
TODD SPANGLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Bills named: S. 1379 (116th)

Health Issues HCR

H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to hazardous drug safety Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy

LobbyistCovered position, as disclosed
JESSICA JOHNSTON —
ADAM LOTSPIKE —
DANNY LY —
TODD SPANGLER —
ELIZABETH WOODY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 3129 (116th), H.R. 2064 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.